# Profusa, Inc. (PFSA)

- Sector: Healthcare · Industry: Medical Devices
- SEC CIK: 0001859807 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001859807))
- Full page: https://inspectstocks.com/stocks/pfsa
- Data as of: price 2026-09-28; newest filing used 2026-08-19; latest fiscal period ended 2026-06-30

## Grade

**F** on the balance-sheet rubric used for lenders, 0 of 4 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -$43M |  |
| Earnings growing overall | failed | -$43M | $3.5M |
| Earnings growing recently | failed | -$43M | -$35.8M |
| Earns well on its assets | failed | -4,123.8% |  |
| Book value per share growing | not answerable | -$79.63 | -$0.12 |

Business quality (the + / − mark): 2 of 6 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -42,970.0% |  |
| Healthy profit margin | failed | -42,970.0% |  |
| Strong operating margin | failed | -31,830.0% |  |
| Good return on equity | passed | 161.2% |  |
| Debt under control | passed | -0.30 |  |
| Turns sales into cash | failed | -16,256.0% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $100K |
| Net income, trailing twelve months | -$43M |
| Free cash flow, trailing twelve months | -$16.3M |
| Net margin | -42,970.0% |
| Operating margin | -31,830.0% |
| Return on equity | 161.2% |
| Debt to equity | -0.30 |
| Share price | $1.73 |
| Market value | $64.7K |
| Price / sales | 0.6x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/pfsa)
- [Financial statements](https://inspectstocks.com/stocks/pfsa/financials)
- [Competitors](https://inspectstocks.com/stocks/pfsa/peers)
- [Earnings](https://inspectstocks.com/stocks/pfsa/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.